These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31915895)

  • 1. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial.
    de Groot PF; Nikolic T; Imangaliyev S; Bekkering S; Duinkerken G; Keij FM; Herrema H; Winkelmeijer M; Kroon J; Levin E; Hutten B; Kemper EM; Simsek S; Levels JHM; van Hoorn FA; Bindraban R; Berkvens A; Dallinga-Thie GM; Davids M; Holleman F; Hoekstra JBL; Stroes ESG; Netea M; van Raalte DH; Roep BO; Nieuwdorp M
    Diabetologia; 2020 Mar; 63(3):597-610. PubMed ID: 31915895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production.
    Endesfelder D; Engel M; Davis-Richardson AG; Ardissone AN; Achenbach P; Hummel S; Winkler C; Atkinson M; Schatz D; Triplett E; Ziegler AG; zu Castell W
    Microbiome; 2016 Apr; 4():17. PubMed ID: 27114075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Roshanravan N; Alamdari NM; Jafarabadi MA; Mohammadi A; Shabestari BR; Nasirzadeh N; Asghari S; Mansoori B; Akbarzadeh M; Ghavami A; Ghaffari S; Ostadrahimi A
    Cytokine; 2020 Jul; 131():155101. PubMed ID: 32315958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial.
    Assfalg R; Knoop J; Hoffman KL; Pfirrmann M; Zapardiel-Gonzalo JM; Hofelich A; Eugster A; Weigelt M; Matzke C; Reinhardt J; Fuchs Y; Bunk M; Weiss A; Hippich M; Halfter K; Hauck SM; Hasford J; Petrosino JF; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2021 May; 64(5):1079-1092. PubMed ID: 33515070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.
    Facchin S; Vitulo N; Calgaro M; Buda A; Romualdi C; Pohl D; Perini B; Lorenzon G; Marinelli C; D'Incà R; Sturniolo GC; Savarino EV
    Neurogastroenterol Motil; 2020 Oct; 32(10):e13914. PubMed ID: 32476236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
    Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
    Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice.
    Xu YH; Gao CL; Guo HL; Zhang WQ; Huang W; Tang SS; Gan WJ; Xu Y; Zhou H; Zhu Q
    J Endocrinol; 2018 Sep; 238(3):231-244. PubMed ID: 29941502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation.
    Bell KJ; Saad S; Tillett BJ; McGuire HM; Bordbar S; Yap YA; Nguyen LT; Wilkins MR; Corley S; Brodie S; Duong S; Wright CJ; Twigg S; de St Groth BF; Harrison LC; Mackay CR; Gurzov EN; Hamilton-Williams EE; Mariño E
    Microbiome; 2022 Jan; 10(1):9. PubMed ID: 35045871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could the use of butyric acid have a positive effect on microbiota and treatment of type 2 diabetes?
    Stachowska E; Wiśniewska M; Dzieżyc A; Bohatyrewicz A
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4570-4578. PubMed ID: 34286509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
    van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
    J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.
    Rodrigues KB; Dufort MJ; Llibre A; Speake C; Rahman MJ; Bondet V; Quiel J; Linsley PS; Greenbaum CJ; Duffy D; Tarbell KV
    Diabetologia; 2020 Aug; 63(8):1576-1587. PubMed ID: 32500289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic alterations in immune cells associate with progression to type 1 diabetes.
    Sen P; Dickens AM; López-Bascón MA; Lindeman T; Kemppainen E; Lamichhane S; Rönkkö T; Ilonen J; Toppari J; Veijola R; Hyöty H; Hyötyläinen T; Knip M; Orešič M
    Diabetologia; 2020 May; 63(5):1017-1031. PubMed ID: 32043185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut immune system and type 1 diabetes.
    Vaarala O
    Ann N Y Acad Sci; 2002 Apr; 958():39-46. PubMed ID: 12021082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
    Parvanova A; Trillini M; Podestà MA; Iliev IP; Ruggiero B; Abbate M; Perna A; Peraro F; Diadei O; Rubis N; Gaspari F; Carrara F; Stucchi N; Belviso A; Bossi AC; Trevisan R; Remuzzi G; de Borst M; Ruggenenti P;
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):27-40. PubMed ID: 29104158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.
    Boon MR; Hanssen MJW; Brans B; Hülsman CJM; Hoeks J; Nahon KJ; Bakker C; van Klinken JB; Havekes B; Schaart G; Jazet IM; Rensen PCN; van Marken Lichtenbelt WD
    Diabetologia; 2019 Jan; 62(1):112-122. PubMed ID: 30377712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.
    Bouter K; Bakker GJ; Levin E; Hartstra AV; Kootte RS; Udayappan SD; Katiraei S; Bahler L; Gilijamse PW; Tremaroli V; Stahlman M; Holleman F; van Riel NAW; Verberne HJ; Romijn JA; Dallinga-Thie GM; Serlie MJ; Ackermans MT; Kemper EM; Willems van Dijk K; Backhed F; Groen AK; Nieuwdorp M
    Clin Transl Gastroenterol; 2018 May; 9(5):155. PubMed ID: 29799027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrate and hexanoate-enriched triglycerides increase postprandrial systemic butyrate and hexanoate in men with overweight/obesity: A double-blind placebo-controlled randomized crossover trial.
    van Deuren T; Smolders L; Hartog A; Bouwman FG; Holst JJ; Venema K; Blaak EE; Canfora EE
    Front Nutr; 2022; 9():1066950. PubMed ID: 36687671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males.
    Cleophas MCP; Ratter JM; Bekkering S; Quintin J; Schraa K; Stroes ES; Netea MG; Joosten LAB
    Sci Rep; 2019 Jan; 9(1):775. PubMed ID: 30692581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human intestinal microbiota and type 1 diabetes.
    Vaarala O
    Curr Diab Rep; 2013 Oct; 13(5):601-7. PubMed ID: 23934614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.